On Oct. 10, the People’s Government of Pingshan District signed a strategic cooperation agreement with Shenzhen Technology University (SZTU) and Shenzhen Investment Holdings Co. Ltd. SZTU also concluded a technology commercialization cooperation agreement with the Science, Technology and Innovation Bureau of Pingshan District and Shenzhen High‑Tech Zone Investment Development Group Co., Ltd.
The agreements aim to strengthen links among talent, innovation and capital to drive high‑quality development in Pingshan and the Guangdong‑Hong Kong‑Macao Greater Bay Area.
Under the strategic framework, partners will cooperate across five areas to create a “government‑industry‑university‑research‑application” ecosystem: talent cultivation, collaborative innovation, industry co‑development, financial support and entrepreneurship.
Key initiatives include a dual‑mentor training system and practical training bases jointly established by SZTU and leading Pingshan companies, with a goal of training 1,000 cross‑disciplinary professionals skilled in both R&D and industrial application within five years.
The partnership will promote research commercialization in fields such as new materials and biopharmaceuticals and develop four strategic industry clusters: intelligent connected vehicles and new energy vehicles, biopharmaceuticals and health, integrated circuits and artificial intelligence, and the low‑altitude economy.
A dedicated industrial development fund will increase investment and accelerate incubation, while efforts to develop the innovation and industrial belt surrounding SZTU will be intensified, with high-level innovation and entrepreneurship events to be organized.
The technology commercialization agreement sets five‑year targets for infrastructure, platform operations, and application promotion. SZTU will partner with Pingshan companies to establish national and provincial innovation platforms, proof‑of‑concept and pilot production bases, offer incubation and site services, and support project development through research funding, standards work and market deployment.